Skip to content
ClinicCompass
Injectables

Xeomin

A neuromodulator in the same class as Botox, purified to contain only the active toxin with no accessory proteins, which is why it is nicknamed the naked Botox. Same uses, similar dosing and duration, and the usual choice for people who have developed resistance to other brands.

Also called: incobotulinumtoxinA, xeomin injections, naked botox

Medically reviewed by Dr. Victoria Taraska, MD, FRCPC

Xeomin
Typical cost

$10–$16

per unit

Sessions

Every 3 to 4 months, like all neuromodulators

typical course

Downtime

None; possible pinpoint bruising

Estimate your Xeomin cost by city →

Xeomin is the third of the major neuromodulators after Botox and Dysport, and the one built on a specific idea: strip the product down to the active toxin alone. Botox and Dysport carry accessory proteins that come along with the toxin during manufacturing. Xeomin removes them. For most people that changes nothing about the result. For the minority whose bodies have learned to fight those proteins, it changes everything.

What it does

The same thing every neuromodulator does. Injected into a muscle, it blocks the nerve signal that makes the muscle contract, the muscle relaxes, and the line it was carving softens. Xeomin is approved for frown lines and used across the upper face and elsewhere exactly as Botox is. Dosing converts one to one, so an injector who uses twenty units of Botox for your frown uses twenty units of Xeomin. Onset is three to five days, full effect at two weeks, and the result lasts three to four months.

Why choose it

The clearest reason is fading response. After years of regular treatment, a small share of people find their Botox or Dysport lasting six weeks instead of twelve, and antibodies to the accessory proteins are the usual cause. Switching to a product without those proteins typically restores the response. Injectors also reach for Xeomin when they prefer its feel for certain areas, when a clinic’s pricing favors it, or when a patient simply asks for a product with fewer additives.

If you are new to neuromodulators, Xeomin is a fine first product and no better or worse than the others in trained hands. If you have been treated for years and something has changed, it is the product to ask about.

What it costs

Per unit, $10 to $16, commonly a little below Botox at the same clinic. Frown lines run about twenty units; the full upper face forty to sixty. Compare treatments by total units and total price rather than by per-unit rate alone.

Choosing an injector

The brand matters far less than the hands. Ask how many neuromodulator treatments the injector does a month, which brands they carry and why, and to see results at two weeks on faces like yours. If you are switching because your response faded, say so; a good injector will confirm the pattern before recommending the change.

Browse the clinics below and compare Xeomin providers and per-unit pricing by city.

Why people choose Xeomin

  • Identical uses and results to Botox with unit-for-unit dosing
  • No accessory proteins, so it is less likely to trigger the antibodies that reduce response over time
  • Does not need refrigeration before mixing, which matters to clinics more than patients
  • Often priced slightly below Botox for the same treatment
Are you a good candidate?

Anyone treating frown lines, forehead lines, or crow's feet, and specifically people whose response to Botox or Dysport has faded over the years, or who prefer a product without added proteins

By location

Find Xeomin near you

765 clinics across 251 cities list Xeomin on ClinicCompass. 510 of them (67%) say on their own websites that they offer financing or payment plans; ask about approval and interest before you book.

Austin Texas Charlotte North Carolina Nashville Tennessee Tampa Florida Miami Florida Phoenix Arizona Denver Colorado Atlanta Georgia Dallas Texas Toronto Ontario Seattle Washington Boston Massachusetts Chicago Illinois Houston Texas Los Angeles California New York New York San Diego California Portland Oregon Minneapolis Minnesota Las Vegas Nevada Orlando Florida San Francisco California Philadelphia Pennsylvania Detroit Michigan Lubbock Texas Scottsdale Arizona Vancouver British Columbia Fort Lauderdale Florida San Antonio Texas Montreal Quebec Washington District of Columbia West Palm Beach Florida Newport Beach California Beverly Hills California Sacramento California Salt Lake City Utah San Jose California Fort Worth Texas Raleigh North Carolina Baltimore Maryland Columbus Ohio Indianapolis Indiana Kansas City Missouri St. Louis Missouri Jacksonville Florida Cleveland Ohio Pittsburgh Pennsylvania Cincinnati Ohio Oklahoma City Oklahoma Tucson Arizona New Orleans Louisiana Edmonton Alberta Winnipeg Manitoba Mississauga Ontario Boise Idaho Colorado Springs Colorado Charleston South Carolina Tulsa Oklahoma Reno Nevada Fresno California Chattanooga Tennessee Columbus Georgia Maui Hawaii Frisco Texas Greenville South Carolina Sioux Falls South Dakota Long Island New York Queens New York Brooklyn New York Hoboken New Jersey Jersey City New Jersey Coral Gables Florida Surrey British Columbia Palo Alto California Rochester Minnesota Buffalo New York La Jolla California Baton Rouge Louisiana Gilbert Arizona Naples Florida Torrance California Albuquerque New Mexico Boca Raton Florida Rochester New York El Paso Texas Southlake Texas Corpus Christi Texas Fort Wayne Indiana Naperville Illinois Tacoma Washington Temecula California The Woodlands Texas Madison Wisconsin Henderson Nevada Katy Texas Pasadena California Wilmington North Carolina Wilmington Delaware Chandler Arizona Tuscaloosa Alabama Anchorage Alaska Irvine California Long Beach California Schaumburg Illinois Glendale California Spokane Washington Tallahassee Florida Waco Texas Winter Park Florida Bellingham Washington Franklin Tennessee Huntsville Alabama Carlsbad California Portland Maine Sarasota Florida Des Moines Iowa Memphis Tennessee Burlington Ontario Delray Beach Florida St. George Utah Castle Rock Colorado Charlottesville Virginia McKinney Texas Annapolis Maryland Cherry Creek Colorado Columbia South Carolina Columbia Missouri Fargo North Dakota Fayetteville North Carolina Fort Myers Florida Lancaster Pennsylvania Redding California Summerlin Nevada Fayetteville Arkansas Boulder Colorado Buckhead Georgia Palm Springs California Worcester Massachusetts Oak Brook Illinois Ventura California Cary North Carolina Albany New York Amarillo Texas Kirkland Washington Bakersfield California Burbank California McAllen Texas Savannah Georgia Springfield Illinois Springfield Massachusetts Springfield Missouri Springfield Ohio Frederick Maryland Oakville Ontario Evansville Indiana Yuma Arizona Grand Junction Colorado Montgomery Alabama Birmingham Alabama Peoria Illinois West Hollywood California Marietta Georgia Olympia Washington Richmond British Columbia Grand Rapids Michigan Mobile Alabama Pensacola Florida Stockton California Tyler Texas Richmond Hill Ontario Pleasanton California Abilene Texas Medford Oregon Napa California Harrisburg Pennsylvania Aventura Florida Round Rock Texas Alpharetta Georgia Arlington Texas Arlington Virginia Cedar Rapids Iowa Fort Collins Colorado Monterey California Palm Desert California Rockford Illinois Staten Island New York Prescott Arizona Carmel Indiana Clarksville Tennessee Roanoke Virginia Gatineau Quebec King of Prussia Pennsylvania Destin Florida Ann Arbor Michigan Knoxville Tennessee Manhattan New York Modesto California Odessa Texas Riverside California Santa Fe New Mexico Santa Monica California Santa Rosa California Sugar Land Texas Winston-Salem North Carolina Roseville California Murfreesboro Tennessee West Hartford Connecticut Brampton Ontario Key West Florida Kissimmee Florida Davenport Iowa Manchester New Hampshire Windsor Ontario Cape Cod Massachusetts Burlington Vermont Honolulu Hawaii Las Cruces New Mexico San Mateo California Santa Barbara California Sioux City Iowa Visalia California Norman Oklahoma Spartanburg South Carolina Cherry Hill New Jersey Bend Oregon Venice Florida New Haven Connecticut Jackson Tennessee Akron Ohio Bozeman Montana Huntington Beach California Louisville Kentucky Oakland California Providence Rhode Island San Luis Obispo California Shreveport Louisiana Vero Beach Florida Lehi Utah Broken Arrow Oklahoma Roswell Georgia Johns Creek Georgia Lynchburg Virginia Allentown Pennsylvania Syracuse New York Durham North Carolina Bradenton Florida Edina Minnesota Mesa Arizona Port St. Lucie Florida Provo Utah Salem Oregon
Know before you book

Xeomin guides & cost breakdowns

Honest, in-depth reading to help you compare options and budget with confidence.

Frequently asked

Xeomin questions, answered

Is Xeomin as good as Botox?

In head-to-head trials for frown lines, Xeomin and Botox performed comparably at the same unit dose, with similar onset and duration. Some injectors and patients report Xeomin feeling slightly softer or wearing off slightly sooner; others notice no difference. It is a legitimate alternative rather than a lesser one, and dosing converts roughly one to one, an industry rule of thumb rather than a label claim.

Why do people switch to Xeomin?

The most common reason is fading response. A small number of long-term Botox or Dysport users develop antibodies to the accessory proteins in those products, and their treatments stop lasting. Xeomin has no accessory proteins, so it is the standard switch when that happens. The other reasons are price, availability, and injector preference.

How long does it take to work and how long does it last?

Onset around three to five days, full effect at two weeks, and three to four months of result, essentially matching Botox. Because it is dosed roughly unit for unit, the same number of units usually treats the same area.

What does it cost?

Per unit, typically $10 to $16, often a dollar or two under Botox at the same clinic. Frown lines take about twenty units, so a treatment runs $200 to $350. Ask for the unit count with the price so you can compare across brands and clinics.

Sources

Where this information comes from

Clinical facts on this page are checked against these primary sources.

  1. 1.XEOMIN (incobotulinumtoxinA) for injection, for intramuscular or intraglandular use: Prescribing Information, U.S. Food and Drug AdministrationFDA approval for moderate to severe glabellar lines, horizontal forehead lines, and lateral canthal lines (crow's feet) in adults; the boxed warning on distant spread of toxin effect; that median onset occurs within two to seven days with a typical duration of effect up to 12 to 16 weeks (about three to four months); that XEOMIN is manufactured without accessory (complexing) proteins; that unopened vials do not require refrigeration; and, importantly, that XEOMIN's potency units cannot be compared to or converted into units of any other botulinum toxin product.
  2. 2.A new treatment for focal dystonias: incobotulinumtoxinA (Xeomin), a botulinum neurotoxin type A free from complexing proteins, National Library of Medicine, PubMed Central (National Institutes of Health)Confirms incobotulinumtoxinA is the only botulinum toxin product free of complexing (accessory) proteins, and that the complexing proteins in conventional formulations may increase antigenicity risk and possibly lead to treatment failure, the rationale for switching to Xeomin when response to another brand fades.
  3. 3.Neuromodulators, American Society for Dermatologic SurgeryNames Xeomin alongside Botox, Dysport, and Jeuveau as a neuromodulator used for frown lines, forehead lines, and crow's feet, with minimal pain, virtually no recovery time, and effects lasting about three months.
  4. 4.Botulinum Toxin, American Society of Plastic SurgeonsLists Xeomin among the FDA-approved botulinum toxin brands and confirms the mechanism: injections block the nerve signal to the injected muscle so it cannot contract.